世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Implantable Venous Access Port - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Implantable Venous Access Port was estimated to be worth US$ 565 million in 2024 and is forecast to a readjusted size of US$ 680 million by 2031 with a CAGR of 2.7% during the... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Implantable Venous Access Port was estimated to be worth US$ 565 million in 2024 and is forecast to a readjusted size of US$ 680 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Implantable Venous Access Port cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations. An Implantable Venous Access Port is a small medical device surgically placed under the skin, typically in the chest or upper arm, that provides long-term venous access for the administration of medications, fluids, blood products, or for blood withdrawal. It consists of a reservoir (port) connected to a catheter that is inserted into a large central vein. Commonly used in patients undergoing chemotherapy, long-term antibiotic therapy, or total parenteral nutrition, the port allows repeated access to the bloodstream while minimizing the discomfort and risk associated with frequent needle sticks. The market for implantable venous access ports is experiencing strong growth driven by the increasing prevalence of chronic diseases that require long-term intravenous therapy, such as cancer, chronic infections, and gastrointestinal disorders. With the global rise in cancer incidence, particularly among aging populations, the need for reliable and long-term vascular access for chemotherapy has grown substantially. Implantable ports offer advantages over traditional peripheral lines, including reduced risk of infection, improved patient comfort, and better long-term cost efficiency, making them the preferred choice in many clinical settings. Additionally, advancements in port design, such as smaller sizes, MRI compatibility, and improved biocompatibility, are enhancing clinical outcomes and patient acceptance. The expansion of healthcare infrastructure in emerging economies, combined with greater awareness among physicians and patients regarding the benefits of implantable ports, is also fueling adoption. Furthermore, rising healthcare expenditure and supportive reimbursement policies in developed markets provide a conducive environment for the widespread use of these devices. Despite the growing demand, the implantable venous access port market faces several significant challenges. One major barrier is the high upfront cost of the devices and the surgical procedures required for implantation, which may limit access in low- and middle-income countries with constrained healthcare budgets. Additionally, the need for skilled healthcare professionals to perform the implantation and manage port-related complications, such as infections, thrombosis, or device malfunction, can strain healthcare systems lacking sufficient training or resources. Another challenge is the risk of long-term complications, which may deter physicians or patients from opting for this solution unless absolutely necessary. Regulatory hurdles and lengthy approval processes for new device innovations can also slow down market penetration for advanced technologies. Moreover, in outpatient and home-care settings, the management of implantable ports requires proper training and hygiene practices, which, if neglected, could increase the risk of adverse events. These technical, economic, and regulatory obstacles must be addressed to ensure broader accessibility and to maximize the clinical benefits of implantable venous access ports globally. This report aims to provide a comprehensive presentation of the global market for Implantable Venous Access Port, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Implantable Venous Access Port by region & country, by Type, and by Application. The Implantable Venous Access Port market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Venous Access Port. Market Segmentation By Company BD AngioDynamics ICU Medical B. Braun Medical PFM Medical Vygon Districlass PakuMed Linhua Medical Fresenius Sophysa Baxter Segment by Type Titanium Infusion Port Plastic Infusion Port Segment by Application Intravenous Chemotherapy Nutritional Support Treatment By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Implantable Venous Access Port manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Implantable Venous Access Port in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Implantable Venous Access Port in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Implantable Venous Access Port Product Introduction 1.2 Global Implantable Venous Access Port Market Size Forecast 1.2.1 Global Implantable Venous Access Port Sales Value (2020-2031) 1.2.2 Global Implantable Venous Access Port Sales Volume (2020-2031) 1.2.3 Global Implantable Venous Access Port Sales Price (2020-2031) 1.3 Implantable Venous Access Port Market Trends & Drivers 1.3.1 Implantable Venous Access Port Industry Trends 1.3.2 Implantable Venous Access Port Market Drivers & Opportunity 1.3.3 Implantable Venous Access Port Market Challenges 1.3.4 Implantable Venous Access Port Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Implantable Venous Access Port Players Revenue Ranking (2024) 2.2 Global Implantable Venous Access Port Revenue by Company (2020-2025) 2.3 Global Implantable Venous Access Port Players Sales Volume Ranking (2024) 2.4 Global Implantable Venous Access Port Sales Volume by Company Players (2020-2025) 2.5 Global Implantable Venous Access Port Average Price by Company (2020-2025) 2.6 Key Manufacturers Implantable Venous Access Port Manufacturing Base and Headquarters 2.7 Key Manufacturers Implantable Venous Access Port Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Implantable Venous Access Port 2.9 Implantable Venous Access Port Market Competitive Analysis 2.9.1 Implantable Venous Access Port Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Implantable Venous Access Port Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Venous Access Port as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Titanium Infusion Port 3.1.2 Plastic Infusion Port 3.2 Global Implantable Venous Access Port Sales Value by Type 3.2.1 Global Implantable Venous Access Port Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Implantable Venous Access Port Sales Value, by Type (2020-2031) 3.2.3 Global Implantable Venous Access Port Sales Value, by Type (%) (2020-2031) 3.3 Global Implantable Venous Access Port Sales Volume by Type 3.3.1 Global Implantable Venous Access Port Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Implantable Venous Access Port Sales Volume, by Type (2020-2031) 3.3.3 Global Implantable Venous Access Port Sales Volume, by Type (%) (2020-2031) 3.4 Global Implantable Venous Access Port Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Intravenous Chemotherapy 4.1.2 Nutritional Support Treatment 4.2 Global Implantable Venous Access Port Sales Value by Application 4.2.1 Global Implantable Venous Access Port Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Implantable Venous Access Port Sales Value, by Application (2020-2031) 4.2.3 Global Implantable Venous Access Port Sales Value, by Application (%) (2020-2031) 4.3 Global Implantable Venous Access Port Sales Volume by Application 4.3.1 Global Implantable Venous Access Port Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Implantable Venous Access Port Sales Volume, by Application (2020-2031) 4.3.3 Global Implantable Venous Access Port Sales Volume, by Application (%) (2020-2031) 4.4 Global Implantable Venous Access Port Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Implantable Venous Access Port Sales Value by Region 5.1.1 Global Implantable Venous Access Port Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Implantable Venous Access Port Sales Value by Region (2020-2025) 5.1.3 Global Implantable Venous Access Port Sales Value by Region (2026-2031) 5.1.4 Global Implantable Venous Access Port Sales Value by Region (%), (2020-2031) 5.2 Global Implantable Venous Access Port Sales Volume by Region 5.2.1 Global Implantable Venous Access Port Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Implantable Venous Access Port Sales Volume by Region (2020-2025) 5.2.3 Global Implantable Venous Access Port Sales Volume by Region (2026-2031) 5.2.4 Global Implantable Venous Access Port Sales Volume by Region (%), (2020-2031) 5.3 Global Implantable Venous Access Port Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Implantable Venous Access Port Sales Value, 2020-2031 5.4.2 North America Implantable Venous Access Port Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Implantable Venous Access Port Sales Value, 2020-2031 5.5.2 Europe Implantable Venous Access Port Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Implantable Venous Access Port Sales Value, 2020-2031 5.6.2 Asia Pacific Implantable Venous Access Port Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Implantable Venous Access Port Sales Value, 2020-2031 5.7.2 South America Implantable Venous Access Port Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Implantable Venous Access Port Sales Value, 2020-2031 5.8.2 Middle East & Africa Implantable Venous Access Port Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Implantable Venous Access Port Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Implantable Venous Access Port Sales Value and Sales Volume 6.2.1 Key Countries/Regions Implantable Venous Access Port Sales Value, 2020-2031 6.2.2 Key Countries/Regions Implantable Venous Access Port Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Implantable Venous Access Port Sales Value, 2020-2031 6.3.2 United States Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Implantable Venous Access Port Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Implantable Venous Access Port Sales Value, 2020-2031 6.4.2 Europe Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Implantable Venous Access Port Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Implantable Venous Access Port Sales Value, 2020-2031 6.5.2 China Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031 6.5.3 China Implantable Venous Access Port Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Implantable Venous Access Port Sales Value, 2020-2031 6.6.2 Japan Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Implantable Venous Access Port Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Implantable Venous Access Port Sales Value, 2020-2031 6.7.2 South Korea Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Implantable Venous Access Port Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Implantable Venous Access Port Sales Value, 2020-2031 6.8.2 Southeast Asia Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Implantable Venous Access Port Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Implantable Venous Access Port Sales Value, 2020-2031 6.9.2 India Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031 6.9.3 India Implantable Venous Access Port Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 BD 7.1.1 BD Company Information 7.1.2 BD Introduction and Business Overview 7.1.3 BD Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 BD Implantable Venous Access Port Product Offerings 7.1.5 BD Recent Development 7.2 AngioDynamics 7.2.1 AngioDynamics Company Information 7.2.2 AngioDynamics Introduction and Business Overview 7.2.3 AngioDynamics Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 AngioDynamics Implantable Venous Access Port Product Offerings 7.2.5 AngioDynamics Recent Development 7.3 ICU Medical 7.3.1 ICU Medical Company Information 7.3.2 ICU Medical Introduction and Business Overview 7.3.3 ICU Medical Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 ICU Medical Implantable Venous Access Port Product Offerings 7.3.5 ICU Medical Recent Development 7.4 B. Braun Medical 7.4.1 B. Braun Medical Company Information 7.4.2 B. Braun Medical Introduction and Business Overview 7.4.3 B. Braun Medical Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 B. Braun Medical Implantable Venous Access Port Product Offerings 7.4.5 B. Braun Medical Recent Development 7.5 PFM Medical 7.5.1 PFM Medical Company Information 7.5.2 PFM Medical Introduction and Business Overview 7.5.3 PFM Medical Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 PFM Medical Implantable Venous Access Port Product Offerings 7.5.5 PFM Medical Recent Development 7.6 Vygon 7.6.1 Vygon Company Information 7.6.2 Vygon Introduction and Business Overview 7.6.3 Vygon Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Vygon Implantable Venous Access Port Product Offerings 7.6.5 Vygon Recent Development 7.7 Districlass 7.7.1 Districlass Company Information 7.7.2 Districlass Introduction and Business Overview 7.7.3 Districlass Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Districlass Implantable Venous Access Port Product Offerings 7.7.5 Districlass Recent Development 7.8 PakuMed 7.8.1 PakuMed Company Information 7.8.2 PakuMed Introduction and Business Overview 7.8.3 PakuMed Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 PakuMed Implantable Venous Access Port Product Offerings 7.8.5 PakuMed Recent Development 7.9 Linhua Medical 7.9.1 Linhua Medical Company Information 7.9.2 Linhua Medical Introduction and Business Overview 7.9.3 Linhua Medical Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Linhua Medical Implantable Venous Access Port Product Offerings 7.9.5 Linhua Medical Recent Development 7.10 Fresenius 7.10.1 Fresenius Company Information 7.10.2 Fresenius Introduction and Business Overview 7.10.3 Fresenius Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 Fresenius Implantable Venous Access Port Product Offerings 7.10.5 Fresenius Recent Development 7.11 Sophysa 7.11.1 Sophysa Company Information 7.11.2 Sophysa Introduction and Business Overview 7.11.3 Sophysa Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Sophysa Implantable Venous Access Port Product Offerings 7.11.5 Sophysa Recent Development 7.12 Baxter 7.12.1 Baxter Company Information 7.12.2 Baxter Introduction and Business Overview 7.12.3 Baxter Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 Baxter Implantable Venous Access Port Product Offerings 7.12.5 Baxter Recent Development 8 Industry Chain Analysis 8.1 Implantable Venous Access Port Industrial Chain 8.2 Implantable Venous Access Port Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Implantable Venous Access Port Sales Model 8.5.2 Sales Channel 8.5.3 Implantable Venous Access Port Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の 医療機器・消耗品分野 での最新刊レポート
本レポートと同じKEY WORD（demand）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
